@Hannibal42

« constat de faits qui le sont et dont vous semblez minimiser voir nier l’existence même  »

Quels sont les faits ?
Parce qu’il y a eu des scandales médicaux qui ne concernent pas les vaccins (Vioxx, et autres), vous en déduisez qu’il doit forcément y avoir un scandale (caché) dans l’industrie du vaccin,

Concernant les effets secondaires des vaccins :

A large study of 790,000 Danish women who received the HPV vaccine found no increased risk of demyelinating diseases, such as transverse myelitis, multiple sclerosis, and other diseases compared to non-vaccinated Danish women. The authors concluded that,

In this study with nationwide coverage of 2 Scandinavian countries, qHPV vaccination was not associated with the development of multiple sclerosis or other demyelinating diseases. These findings do not support concerns about a causal relationship between qHPV vaccination and demyelinating diseases.

Another large study of over 1 million women found no safety signals for autoimmune diseases, neurological and venous thromboembolic (venous blood clots) events in HPV vaccinated women. The researchers deduced that,

This large cohort study found no evidence supporting associations between exposure to qHPV vaccine and autoimmune, neurological, and venous thromboembolic adverse events. Although associations for three autoimmune events were initially observed, on further assessment these were weak and not temporally related to vaccine exposure. Furthermore, the findings need to be interpreted considering the multiple outcomes assessed.

A recent meta-review (considered the pinnacle of biomedical research) of over 100 different safety studies of the HPV vaccine, that included over 2.5 million individuals, found no increased risks of adverse events of special interest (AESI), which are events that can cause serious harm. The authors of this study concluded that,

There was no consistent evidence of an increased risk of any AESI, including demyelinating syndromes or neurological conditions such as complex regional pain or postural orthostatic tachycardia syndromes. The risk-benefit profile for HPV vaccines remains highly favourable.

A peer-reviewed CDC study of 8 years of HPV-vaccine clinical and epidemiological studies found no serious adverse events including TM. Their review of Gardasil safety facts found that,

In the United States, post-licensure vaccine safety monitoring and evaluation are conducted independently by federal agencies and vaccine manufacturers. From June 2006 through March 2014, approximately 67 million doses of HPV4 were distributed in the United States, and from October 2009 through March 2014, a total of 719,000 doses of HPV2 were distributed. Overall, HPV4 has accounted for approximately 99% of doses distributed since 2006. Multiple studies have provided evidence supporting HPV vaccine safety

A study of over 3 million Scandinavian women found no link between the vaccine and demyelinating diseases. The authors stated the following conclusion :

In conclusion, our study of serious adverse event rates in qHPV (quadrivalent Gardasil)-vaccinated and qHPV-unvaccinated adult women 18-44 years of age did not raise any safety issues of concern.

There are at least 10 other large-scale clinical and epidemiological studies that reject the hypothesis of serious adverse events linked to HPV vaccines. These studies included over hundreds of thousands or millions of patients. They are sufficiently powered so that they could potentially uncover even the rarest of adverse events. Yet, they found little to nothing.

Je vous offre le chiffre de 176 sur un plateau. Vous aviez contesté ce chiffre. Et maintenant vous me parlez d’interprétation ??

Quelle est VOTRE interprétation de ce chiffe que je comprennes où vous voulez en venir !!! ??